Table 2

Background of colorectal cancer patients with serum TFF3 analysis
Item Cases (n) Serum TFF3 (ng/ml) P-value
Age
 ≤60 70 13.09 ± 0.95 0.0061
 >60 58 19.20 ± 2.11
Gender
 Male 75 16.14 ± 1.42 0.7699
 Female 53 15.47 ± 1.82
Site
 Colon 67 15.86 ± 1.57 0.9957
 Rectum 61 15.47 ± 1.82
Degree of differentiation
 Well-moderately 107 20.66 ± 3.74 0.057
 Poorly 21 14.92 ± 1.11
Stage (I-III VS IV) 0.0007
 I 11 11.32 ± 2.21
 II 30 12.20 ± 0.88
 III 25 14.27 ± 2.89
 IV 45 21.82 ± 2.39
Lymphatic metastasis
 N(-) 46 11.86 ± 0.79 0.1786
 N(+) 33 14.70 ± 2.22
  N1 19 10.45 ± 1.09 0.00229
  N2 14 20.47 ± 1.98
Distant metastasis
 M0 84 12.86 ± 0.99 0.001
 M1 44 21.59 ± 2.44

Xiao et al.

Xiao et al. BMC Clinical Pathology 2014 14:26   doi:10.1186/1472-6890-14-26

Open Data